Huyen Tran

Professor
Australian Centre for Blood Diseases, Monash University
Melbourne, Victoria, Australia

Presentation(s):

• OC 20.3 - Improved Joint Health After Gene Therapy with Dirloctocogene Samoparvovec (SPK-8011) in People with Hemophilia A

  Sunday, June 25, 2023
  15:15 – 15:30 ET

• PB0188 - Improved Quality of Life in People with Hemophilia A Following Gene Therapy with Dirloctocogene Samoparvovec (SPK-8011)

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0193 - Financial impact of switching to emicizumab from conventional haemostatic agents in acquired haemophilia A

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0194 - Comparison of intraindividual bleeding outcomes pre- and post-emicizumab in Australian adults and children with haemophilia A with and without inhibitors: a nationwide real-world experience

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0505 - Outcomes of patients with pulmonary embolism admitted to the Intensive Care Unit

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• OC 34.4 - Post thrombotic syndrome in idiopathic upper extremity deep vein thrombosis

  Monday, June 26, 2023
  11:30 – 11:45 ET

• OC 37.5 - Vaccine-induced immune thrombotic thrombocytopenia produces a marked hyperfibrinolytic state and generates a plasma cofactor that potentiates tPA-mediated plasminogen activation

  Monday, June 26, 2023
  11:45 – 12:00 ET

• PB0647 - Life expectancy and mortality of patients with haemophilia A and haemophilia B in Australia

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0653 - Can thrombin generation assays be used to guide the use of anticoagulants in people with haemophilia? – an exploratory study

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB1016 - Case-control study on dynamic upper limb ultrasound and biomarkers in idiopathic upper extremity deep vein thrombosis

  Monday, June 26, 2023
  18:30 – 19:30 ET

• OC 59.4 - Health-related quality of life, treatment burden and patient preference in patients with haemophilia A/B without inhibitors on concizumab prophylaxis: results from the phase 3 explorer8 study

  Tuesday, June 27, 2023
  15:30 – 15:45 ET